Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System

Mise à jour : Il y a 4 ans
Référence : NCT02097082

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

An evaluation of the safety and performance of the STANZA Drug-eluting Resorbable Scaffold (DRS) system for the treatment of patients with obstructive superficial femoral artery disease.


Critère d'inclusion

  • Peripheral arterial disease,Intermittent claudication,Vascular Diseases,Cardiovascular Diseases

Liens